In 2024, UAB Shapropharma had revenue of 37.5 thousand EUR and loss of 1.5 thousand EUR.
Warning
Possible tax debts
| year | 2024Latest | 2023 |
|---|---|---|
Revenue | 37,5k € | 0 € |
Profit | -1,5k € +43.3% | -2,6k € |
Assets | - | - |
Liabilities | - | - |
Equity | - | - |
Employees | - | - |
Overall rating | C+60/100 |
Financial health | 35/100 |
Credit history | 70/100 |
Legal history | 85/100 |
Business activity | 60/100 |
| Overall risk | Medium |
Possible tax debts | |
Possible tax debts | |
Negative profit | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Male) |
UAB Shapropharma is located at Klaipėda, Sandėlių g. 30, LT-95107, LT-LT-95107.
In 2024, UAB Shapropharma had revenue of 37 503 EUR and loss of 1452 EUR. View full financial report →
The shareholders of UAB Shapropharma include 1 Lithuanian legal entities. View ownership details →
Yes, UAB Shapropharma is registered as an active VAT payer with VAT number LT100016251018.
UAB Shapropharma was founded on August 14, 2023. The company has been operating for 3 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 3 years | 73 - 77 | 19% | |
Net revenue | 37 503,00 € | 68 - 72 | 24% | |
Profit | -1452,00 € | 87 - 91 | 3% | |
Profitability | -3.9% | - | 10% | |
Registered capital | 1000,00 € | - | 10% |
Annual financial report for 2024.
Annual financial report for 2023.
Registered in the Lithuanian register of legal entities.